Ethics, consent and permissions
The study was conducted according to the Declaration of Helsinki and the national research regulations. The study received approval by the Institutional Review Board of Corporación Científica Pediátrica in Cali, Colombia (reference number CEI-060-2016). All subjects who agreed to participate in the research provided written informed consent to participate.
Consent to Publish
No individual patient data is presented, therefore consent to publish was not requested.
Availability of data and material
The datasets generated and analyzed during the current study are available in the REVIVA (Red de VIH de Valle del Cauca) repository and are available from the corresponding author on reasonable request.
Authors' contributions
EMB lead the design, development, data analysis and conclusions of the study, was responsible for the writing of the paper, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
JMO contributed substantially in the design of the study, conduction, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work..
JFG was responsible for the concept idea of the study, contributed substantially in the design, implementation, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
JA contributed with implementation of the study, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work..
WL contributed substantially in the design of the study, implementation, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
LMS contributed substantially in the implementation of the study, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
LCR made major contributions in the design of the study, analysis and interpretation of the results, has approved the submitted revised version of the manuscript, and agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work.
Competing interests
EMB reports research grants from ViiV Healthcare/GSK, financial support for REVIVA foundation and VIHCOL Group (Grupo Colombiano de VIH) from GSK, MSD and Stendhal, and personal fees for presentations and advisory board meetings from GSK, MSD and Stendhal and presentations from Janssen Pharmaceuticals. JMO reports grants from ViiV Healthcare/GlaxoSmithKline, and personal fees from Merck Sharp & Dohme Colombia. JFO reports personal fees from Merck Sharp and Dohme Colombia. JA reports grants from ViiV Healthcare/GlaxoSmithKline and grants and personal fees from Merck Sharp & Dohme Colombia SAS. WL reports grants from ViiV Healthcare/GlaxoSmithKline, personal fees from Janssen Cilag SA, and Merck Sharp & Dohme Colombia; LR reports grants from ViiV Healthcare/GSK and Merck Sharp & Dohme Colombia. LMS declares no conflicts of interest.
Funding
An unrestricted grant provided the funding for this research from ViiV Healthcare to Fundación Red de VIH del Valle del Cauca (REVIVA), Cali, Colombia. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Acknowledgements
We would like to thank the following persons in the participating institutions: SIES Salud (Bogotá: Luis F. Echeverría; Cali: Claudia I. González, Kevin Escandón-Vargas; Medellín: María P. Posada; Pereira: Julieta Franco; Florencia: Andrea C. Rodríguez), Recuperar IPS (Cali: Jorge A. Ramírez, William Lenis), CEPAIN (Bogotá: Mónica Mantilla, Leonardo Arévalo; Cúcuta: Javier Stand; Villavicencio: Wilmar Tobón; Manizales: Angela Cuartas), Asistencia Científica de Alta Complejidad (Bogotá: Otto Sussmann), Medicina Integral (Danitza Hernández; Barranquilla: Pierina Di Ruggiero Pertuz); Oncovihda (Barranquilla: Gustavo A. Duncan, Edison Barrera), CDI S.A. (Olga C. Niño; Bucaramanga: Elsa Rojas Garrido), Fundación Caminos (Cartagena: Sandra Alandete, Carlos Castañeda).